X0306 4 2022-01-11 0 0001868734 CinCor Pharma, Inc. CINC 0001245624 HEALY JAMES C/O CINCOR PHARMA, INC 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 1 0 1 0 Common Stock 2022-01-11 4 C 0 5248949 A 5248949 I By Sofinnova Venture Partners X, L.P. Common Stock 2022-01-11 4 P 0 325000 16.00 A 5573949 I By Sofinnova Venture Partners X, L.P. Series A Preferred Stock 2022-01-11 4 C 0 13571428 0.00 D Common Stock 3991596 0 I By Sofinnova Venture Partners X, L.P. Series B Preferred Stock 2022-01-11 4 C 0 4275000 0.00 D Common Stock 1257353 0 I By Sofinnova Venture Partners X, L.P. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date. The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. /s/ Cathy Rude, Attorney-in-Fact 2022-01-13